Skip to content

Journal · Pharmacology · Updated 21 November 2026

Acta Pharmacologica Sinica

Read Acta Pharmacologica Sinica articles on DeepDyve. No university library needed.

Acta Pharmacologica Sinica covers pharmacology and drug discovery, from protein degraders and covalent inhibitor design to gut microbes in kidney fibrosis and ketone treatment for stroke in mice. Springer Nature publishes it. It was previously published as Zhongguo Yao Li Xue Bao. A DeepDyve subscription lets you read it in full, alongside millions of articles from other journals licensed from publishers including Springer Nature.

Then $59 a month or $499 a year. A credit card is required; cancel during the trial and you won’t be charged. You read articles online; PDFs are sold separately.

Personal plans aren’t for business use. Reading for work? See Enterprise.

Cover of Acta Pharmacologica Sinica
November 2026 issue

Acta Pharmacologica Sinica at a glance

Full title
Acta Pharmacologica Sinica
Former title
Zhongguo Yao Li Xue Bao
Abbreviation (NLM)
Acta Pharmacol Sin
Publisher
Springer Nature
Print ISSN
1671-4083
Online ISSN (eISSN)
1745-7254
Current title since
2000
Subjects
Pharmacology
Access model
Hybrid (13% free to read in 2026)

Ways to access Acta Pharmacologica Sinica

13% of the articles Acta Pharmacologica Sinica published from January 1 to November 20, 2026 are open access and free to read. For the rest, look for the authors’ manuscript, check a library, or read them on DeepDyve.

  1. Open access articles. 13% of Acta Pharmacologica Sinica articles published from January 1 to November 20, 2026 carry a Creative Commons license, per Crossref, and are free to read. They’re marked “Open access” below.
  2. The authors’ accepted manuscript. For subscription articles, Springer Nature lets authors make their accepted manuscript public 6 months after publication, on a personal website or in a repository such as PubMed Central.
  3. NIH-funded research. For papers accepted on or after July 1, 2025, the US National Institutes of Health requires the accepted manuscript in PubMed Central, free with no embargo from the official publication date.
  4. A library. Your university, hospital or public library may subscribe to Acta Pharmacologica Sinica. Check its journal list and whether it offers remote access.
  5. DeepDyve. Read Acta Pharmacologica Sinica articles online for $59 a month or $499 a year after a free first month. Articles marked LitStream below are in DeepDyve’s LitStream collection, which a subscription lets you read online. PDFs are sold separately, and availability varies by article.

Sources: Springer Nature self-archiving policy; NIH Public Access Policy; open access share from Crossref license data.

Recent Acta Pharmacologica Sinica research worth reading

Published January to June 2026. Summaries describe what the authors report.

  1. LitStreamKidney fibrosis · Gut microbiota

    Gut microbiota and renal fibrosis: novel mechanistic insights and therapeutic potential

    The authors review how gut microbial imbalance and microbe-derived metabolites such as indoxyl sulphate and TMAO worsen kidney inflammation and fibrosis, and discuss probiotics, natural products and fecal microbiota transplant as possible treatments needing larger controlled trials.

    Liu et al. · Acta Pharmacologica Sinica, published online April 8, 2026 · DOI 10.1038/s41401-026-01801-0

  2. LitStreamCovalent inhibitors · Structure prediction

    Benchmarking co-folding methods to predict the structures of covalent protein–ligand complexes

    Testing docking and deep learning co-folding methods on a benchmark of 218 covalent protein–ligand complexes, the authors report that co-folding models were more accurate but slower and declined markedly on novel pocket–ligand pairs.

    Zhang et al. · Acta Pharmacologica Sinica, published online January 12, 2026 · DOI 10.1038/s41401-025-01721-5

  3. LitStreamER-phagy · Cell biology

    ER-phagy receptors: structural mechanisms in selective ER degradation and disease implications

    The authors review the receptors that drive ER-phagy, the selective breakdown of the endoplasmic reticulum, and the evidence linking its dysfunction to neurological disorders, cancer, metabolic and cardiovascular diseases, infections and immune disorders.

    Yang et al. · Acta Pharmacologica Sinica, published online January 27, 2026 · DOI 10.1038/s41401-025-01724-2

  4. Open accessPROTACs · Drug delivery

    Advancing PROTAC therapeutics through chemistry-guided design of smart delivery systems

    The authors review chemistry-guided delivery strategies for PROTAC protein degraders, from responsive prodrugs and linkers to lipid, polymeric and inorganic nanocarriers and antibody conjugates, as ways to overcome their poor permeability and pharmacokinetics.

    Yao et al. · Acta Pharmacologica Sinica, published online June 25, 2026 · DOI 10.1038/s41401-026-01853-2

  5. LitStreamIschemic stroke · Glymphatic system

    β-Hydroxybutyrate improves glymphatic system function and alleviates cerebral edema in mice after ischemic stroke

    In mice with induced ischemic stroke, the authors report that a ketogenic diet and β-hydroxybutyrate treatment enhanced glymphatic system function, and that β-hydroxybutyrate reduced cerebral edema and infarct volume, likely by restoring AQP4 polarization.

    Yu et al. · Acta Pharmacologica Sinica, published online January 14, 2026 · DOI 10.1038/s41401-025-01706-4

See every Acta Pharmacologica Sinica article on DeepDyve

Questions about Acta Pharmacologica Sinica

How can I read Acta Pharmacologica Sinica articles without a subscription?

13% of Acta Pharmacologica Sinica articles published from January 1 to November 20, 2026 are open access and free to read. For subscription articles, Springer Nature lets authors make their accepted manuscript public 6 months after publication, on a personal website or in a repository such as PubMed Central. Your library may also subscribe. DeepDyve lets you read Acta Pharmacologica Sinica articles online for $59 a month or $499 a year after a free first month.

What is the abbreviation for Acta Pharmacologica Sinica?

Acta Pharmacologica Sinica’s NLM (PubMed) abbreviation is Acta Pharmacol Sin.

What is the ISSN of Acta Pharmacologica Sinica?

The print ISSN is 1671-4083 and the online ISSN is 1745-7254.

Is Acta Pharmacologica Sinica open access?

Acta Pharmacologica Sinica is a hybrid journal: most articles are published under the subscription model, and authors can choose to publish open access. From January 1 to November 20, 2026, 34 of 257 Acta Pharmacologica Sinica articles (13%) carry a Creative Commons license, per Crossref.

Acta Pharmacologica Sinica articles on DeepDyve are licensed from Springer Nature. Journal facts as of 21 November 2026.

Start reading Acta Pharmacologica Sinica today

One month free, then less than $2 a day. Acta Pharmacologica Sinica, plus millions of articles from thousands of journals.

Start free month

Like this: